The worldwide environment of cardiovascular disease: Prevalence, diagnosis, therapy, and policy issues: A report from the american college of cardiology

Journal of the American College of Cardiology

Volumn 60, Issue 25 SUPPL., 2012, Pages

  Laslett, Lawrence J ^a   Alagona, Peter ^b   Clark III, Bernard A ^c   Drozda, Joseph P ^d   Saldivar, Frances ^e   Wilson, Sean R ^f   Poe, Chris ^g   Hart, Menolly ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^d Mercy Health Research   (United States)

^e KAISER PERMANENTE MEDICAL CENTER   (United States)

^f NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^g AMERICAN COLLEGE OF CARDIOLOGY   (United States)

Author keywords

cardiology economic environment; cardiology political environment; cardiology practice trends; cardiology social environment; cardiology statistics

Indexed keywords

ACETYLSALICYLIC ACID; ANACETRAPIB; ATORVASTATIN; CANDESARTAN HEXETIL; CARDIOVASCULAR AGENT; CHOLINE FENOFIBRATE; CLOPIDOGREL; DALCETRAPIB; DIURETIC AGENT; EPTIFIBATIDE; FENOFIBRATE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LOSARTAN POTASSIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID PLUS SIMVASTATIN; OLMESARTAN; TORCETRAPIB; VALSARTAN;

AGING; BLOOD PRESSURE REGULATION; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONGESTIVE CARDIOMYOPATHY; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIET THERAPY; DRUG APPROVAL; DRUG ELUTING STENT; DRUG INDUSTRY; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; DYSLIPIDEMIA; ETHNICITY; FEMALE PHYSICIAN; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; FUNDING; GLYCEMIC CONTROL; GOVERNMENT REGULATION; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE MANPOWER; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEART VALVE PROSTHESIS; HUMAN; HYPERTENSION; INVASIVE PROCEDURE; ISCHEMIC HEART DISEASE; KIDNEY DENERVATION; LOWEST INCOME GROUP; MEDICAID; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICARE; MORTALITY; NON INVASIVE PROCEDURE; NURSING; OBESITY; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC-PRIVATE PARTNERSHIP; RETIREMENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; SYSTOLIC BLOOD PRESSURE; TRANSCATHETER AORTIC VALVE IMPLANTATION; URBANIZATION;

EID: 84871303040     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.002     Document Type: Review

References (189)

1. World Health Organization Cardiovascular Disease: Global Atlas on Cardiovascular Disease Prevention and Control 2012 WHO Geneva, Switzerland
2. S.C. Smith Jr, A. Collins, R. Ferrari Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke) J Am Coll Cardiol 60 2012 2343 2348
3. World Health Organization Global Atlast CVD Prevention/Control 2011 WHO Geneva, Switzerland
4. GHSi Shifting paradigm: how the BRICS are reshaping global health and development 2012 http://www.ghsinitiatives.org/brics-report Accessed November 2012
5. World Health Organization and World Economic Forum From Burden to "Best Buys": Reducing the Economic Impact of NCDs in Low- and Middle-Income Countries 2011 WHO Geneva, Switzerland
6. L. Nainggolan Doing nothing about CVD will cost $47 trillion Heartwire Sept 17, 2012 http://www.theheart.org/article/1447691.do Accessed November 2012
7. D.E. Bloom, E.T. Cafiero, E. Jané-Llopis The Global Economic Burden of Noncommunicable Diseases 2011 World Economic Forum Geneva, Switzerland
8. World Heart Federation Urbanization and Cardiovascular Disease: Raising Heart-Healthy Children in Today's Cities 2012 WHF Geneva, Switzerland
9. T.A. Gaziano Reducing the growing burden of cardiovascular disease in the developing world Health Aff (Project Hope) 26 2007 13 24
10. E.M. Crimmins, J.K. Kim, A. Sole-Auro Gender differences in health: results from SHARE, ELSA and HRS Eur J Pub Health 21 2011 81 91
11. World Health Organization World Health Statistics 2012 2012 WHO Geneva, Switzerland
12. World Health Organization Raised Blood Pressure: Situation and Trends Global Health Observatory 2012 WHO Geneva, Switzerland
13. Organization for Economic Cooperation and Development OECD Health Data 2012 2012 OECD Paris, France
14. R. Lee, A. Mason, D. Cotlear Some economic consequences of global aging A discussion note for the World Bank December 2010 World Bank Washington, DC
15. Department of Economic and Social Affairs Population Division International Migration 2006 2006 United Nations New York, NY
16. M.M. Ibrahim, A. Damasceno Hypertension in developing countries Lancet 380 2012 611 619
17. A.S. Kim, S.C. Johnston Global variation in the relative burden of stroke and ischemic heart disease Circulation 124 2011 314 323
18. National Heart, Lung and Blood Institute NHLBI Funds Research and Training Centers Aimed at Prevention and Treatment of Chronic Diseases in Developing Countries and Collaborates with UnitedHealth Group's Chronic Disease Initiative NIH News 2009 National Institutes of Health Bethesda, MD
19. UnitedHealth and NHLBI Collaborating Centers of Excellence National Heart, Lung and Blood Institute 2012 National Institutes of Health Bethesda, MD
20. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health 2010 National Academy of Sciences Washington DC
21. HINARI HINARI Access to Research in Health Programme 2012 World Health Organization Geneva, Switzerland
22. Centers for Medicare and Medicaid Services National Health Expenditure Projections 2011-2021 2011 CMS Washington, DC
23. S.P. Keehan, G.A. Cuckler, A.M. Sisko National health expenditure projections: modest annual growth until coverage expands and economic growth accelerates Health Aff (Project Hope) 31 2012 1600 1612
24. P.A. Heidenreich, J.G. Trogdon, O.A. Khavjou Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 2011 933 944
25. C.S. Roehrig, D.M. Rousseau The growth in cost per case explains far more of US health spending increases than rising disease prevalence Health Aff (Project Hope) 30 2011 1657 1663
26. Kaiser Family Foundation Summary of New Health Reform Law Focus on Health Reform, 2011 http://www.kff.org/healthreform/8061.cfm Accessed November 2012
27. J.D. Hahn, C.M. Davis The Independent Payment Advisory Board CRS Report for Congress, 2012 http://assets.opencrs.com/rpts/R41511-20120312.pdf Accessed November 2012
28. California HealthCare Foundation US Health Care Spending Health Care Costs 101 2012 California HealthCare Foundation Oakland, CA
29. Centers for Medicare and Medicaid Innovation One Year of Innovation 2012 CMS Washington, DC
30. Centers for Medicare and Medicaid Innovation What We're Doing 2012 CMS Washington, DC
31. American College of Physicians The PCMH in Action Delivery and Payment Models 2012 ACP Philadelphia, PA
32. American College of Physicians The Patient Centered Medical Home and Specialty Physicians Delivery and Payment Models 2012 ACP Philadelphia, PA
33. Centers for Medicare and Medicaid Innovation Federally Qualified Health Center (FQHC) 2012 CMS Washington, DC
34. Centers for Medicare and Medicaid Innovation Innovations Project Profiles 2012 CMS Washington, DC
35. Centers for Medicare and Medicaid Innovation Pioneer Accountable Care Organization Model: General Fact Sheet 2012 CMS Washington, DC
36. Centers for Medicare and Medicaid Services Medicare Physician Group Practice Demonstration 2011 CMS Washington, DC
37. C.H. Colla, D.E. Wennberg, E. Meara Spending differences associated with the Medicare Physician Group Practice Demonstration JAMA 308 2012 1015 1023
38. Centers for Medicare and Medicaid Services CMS Roadmaps for the Traditional Fee-for-Service (FFS) Program: Overview 2011 CMS Washington, DC
39. Centers for Medicare and Medicaid Services Hospital Value-Based Purchasing Program Hospital Quality Initiatives 2011 CMS Washington, DC
40. Centers for Medicare and Medicaid Services National Provider Call: Hospital Value-Based Purchasing 2012 https://www.cms.gov/medicare/quality- initiatives-patient-assessment-instruments/hospital-value-based-purchasing/ downloads/hvbpnpcslides022812-.pdf Accessed June 2012
41. National Quality Forum Measure Applications Partnership: Coordination Strategy for Clinical Performance Measurement 2011 NQF Washington, DC
42. Centers for Medicare and Medicaid Services Physician Feedback Program and Quality and Resource Use Reports (QRURs) Educational Presentation Transcript 2011 CMS Washington, DC
43. National Quality Forum Measure Applications Partnership Strategic Plan: 2012-2015 2012 NQF Washington, DC
44. National Quality Forum MAP Families of Measures: Safety, Care Coordination, Cardiovascular Conditions, Diabetes 2012 NQF Washington, DC
45. Centers for Disease Control and Prevention/National Center for Health Statistics Number of All-listed Procedures for Discharges from Short-Stay Hospitals, by Procedure Category and Sex: United States, 2010 2012 CDC Atlanta, GA
46. V.L. Roger, A.S. Go, D.M. Lloyd-Jones Heart disease and stroke statistics-2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
47. B.W. Andrus, H.G. Welch Medicare services provided by cardiologists in the United States: 1999-2008 Circ Cardiovasc Qual Outcome 5 2012 31 36
48. D.C. Levin, V.M. Rao, L. Parker, A.J. Frangos, J.H. Sunshine Bending the curve: the recent marked slowdown in growth of noninvasive diagnostic imaging AJR Am J Roentgenol 196 2011 W25 W29
49. MedPAC Health Care Spending and the Medicare Program: A Data Book 2012 MedPAC Washington, DC
50. P.A. Hines, K. Yu, M. Randall Preventing heart failure readmissions: is your organization prepared? Nurs Econom 28 2010 74 85
51. S.F. Jencks, M.V. Williams, E.A. Coleman Rehospitalizations among patients in the Medicare fee-for-service program N Engl J Med 360 2009 1418 1428
52. J. Rau Medicare to penalize 2,217 hospitals for excess readmissions Kaiser Health News, 2012 http://www.kaiserhealthnews.org/stories/2012/august/13/ medicare-hospitals-readmissions-penalties.aspx Accessed November 2012
53. Centers for Medicare and Medicaid Services Readmissions Reduction Program Acute Inpatient PPS 2012 CMS Washington, DC
54. Patient-Centered Outcomes Research Institute Patient-Centered Outcomes Research Institute Amends Draft Research Agenda in Response to Public Comment News Room 2012 PCORI Washington, DC
55. Patient-Centered Outcomes Research Institute National Priorities for Research and Research Agenda 2012 PCORI Washington, DC
56. D. Blumenthal, M. Tavenner The "meaningful use" regulation for electronic health records N Engl J Med 363 2010 501 504
57. Centers for Medicare and Medicaid Services Flowchart to Help Eligible Professionals Determine Eligibility for the Medicare Medicaid Electronic Medical Record Incentive Program 2010 CMS Washington, DC
58. MedPAC Raises Concern About Meaningful Use Attestation iHealthBeat: California HealthCare Foundation, 2012 http://www.ihealthbeat.org/articles/2012/ 4/6/medpac-raises-concern-about-meaningful-use-attestation.aspx Accessed November 2012
59. E-Health Record Adoption: A Look Under the Hood iHealthBeat: California HealthCare Foundation, 2012 http://www.ihealthbeat.org/features/2012/ehealth- record-adoption-a-look-under-the-hood.aspx Accessed November 2012
60. S.R. Rao, C.M. Desroches, K. Donelan, E.G. Campbell, P.D. Miralles, A.K. Jha Electronic health records in small physician practices: availability, use, and perceived benefits J Am Med Inform Assoc 18 2011 271 275
61. E. Jamoom, P. Beatty, A. Bercovitz, D. Woodwell, K. Palso, E. Rechtsteiner Physician adoption of electronic health record systems: United States, 2011 NCHS Data Brief 2012 1 8
62. L. Wolf, J. Harvell, A.K. Jha Hospitals ineligible for federal meaningful-use incentives have dismally low rates of adoption of electronic health records Health Aff (Project Hope) 31 2012 505 513
63. A Tough Time for Physicians: 2012 Medical Practice and Attitude Report Jackson Healthcare, 2012 http://www.jacksonhealthcare.com/media-room/surveys/ physician-practice-trends-survey-2012.aspx Accessed November 2012
64. The Physicians Foundation A Survey of America's Physicians: Practice Patterns and Perspectives 2012 http://www.physiciansfoundation.org/healthcare- research/a-survey-of-americas-physicians-practice-patterns-and-perspectives Accessed November 2012
65. Association of American Medical Colleges State Physician Workforce Data Book 2011 AAMC Washington, DC
66. Association of American Medical Colleges The Impact of Health Care Reform on the Future Supply and Demand for Physicians: Updated Projections Through 2025 2010 AAMC Washington, DC
67. J.K. Iglehart Despite tight budgets, boosting US Health workforce may be policy that is "just right." Health Aff (Project Hope) 30 2011 191 192
68. G.P. Rodgers, J.B. Conti, J.A. Feinstein ACC 2009 survey results and recommendations: addressing the cardiology workforce crisis A report of the ACC Board of Trustees Workforce Task Force J Am Coll Cardiol 54 2009 1195 1208
69. The Lewin Group Inc. and Association of American Medical Colleges Cardiovascular Workforce Assessment Final Report 2009 http://content.onlinejacc. org/cgi/data/j.jacc.2009.08.001/DC2/1 Accessed June 2012
70. S. Aneja, J.S. Ross, Y. Wang US cardiologist workforce from 1995 to 2007: modest growth, lasting geographic maldistribution especially in rural areas Health Aff (Project Hope) 30 2011 2301 2309
71. M. MacDowell, M. Glasser, M. Fitts, K. Nielsen, M. Hunsaker A national view of rural health workforce issues in the USA Rural Remote Health 10 2010 1531
72. T.E. Williams Jr., B. Sun, P. Ross Jr., A.M. Thomas A formidable task: population analysis predicts a deficit of 2000 cardiothoracic surgeons by 2030 J Thorac Cardiovasc Surg 139 2010 835 840 discussion 840-1
73. A. Grover, K. Gorman, T.M. Dall Shortage of cardiothoracic surgeons is likely by 2020 Circulation 120 2009 488 494
74. Center for Workforce Studies Results of the 2009 Medical School Enrollment Survey Report to the Council of Deans 2010 https://www.aamc.org/ download/124780/data/enrollment2010.pdf.pdf Accessed November 2012
75. ACGME Accreditation Council for Graduate Medical Education Data Resource Book Academic Year 2010-2011 2011 ACGME Chicago, IL
76. US Census Bureau State and County Quickfacts: USA 2011 US Census Bureau Washington, DC
77. R. Jenkins, R. Kydd, P. Mullen International migration of doctors, and its impact on availability of psychiatrists in low and middle income countries PloS One 5 2010 e9049
78. ACGME Accreditation Council for Graduate Medical Education Data Resource Book: Academic Years 2007-2008/2008-2009/2009-2010 2010 ACGME Chicago, IL
79. J.J. Norcini, J.R. Boulet, W.D. Dauphinee, A. Opalek, I.D. Krantz, S.T. Anderson Evaluating the quality of care provided by graduates of international medical schools Health Aff (Project Hope) 29 2010 1461 1468
80. First Consulting Group The Healthcare Workforce Shortage and Its Implications for America's Hospitals 2001 http://www.fcg.com/webfiles/pdfs/ fcgworkforcereport.pdf Accessed November 2012
81. P.I. Buerhaus, D.I. Auerbach, D.O. Staiger The recent surge in nurse employment: causes and implications Health Aff (Project Hope) 28 2009 w657 w668
82. Health Research Institute Operating Performance in the Medtech Industry: Trends and Imperatives 2012 http://www.pwc.com/us/en/health-industries/ publications/medtech-operating-performance-growth-profitability.jhtml Accessed November 2012
83. Health Research Institute Unleashing Value The Changing Payment Landscape for the US Pharmaceutical Industry http://www.pwc.com/us/en/health-industries/ publications/pharma-reimbursement-value.jhtml Accessed November 2012
84. Press Release: IMS Forecasts Global Pharmaceutical Market Growth of 5-8% Annually Through 2014; Maintains Expectations of 4-6% Growth in 2010 2010 IMS Institute Danbury, CT
85. C. Harrison Patent watch: the patent cliff steepens Nature Rev Drug Discovery 10 2011 12 13
86. M. Goodman Market watch Pharma industry strategic performance: 2007-2012E Nature Rev Drug Discovery 7 2008 967
87. Generic Pharmaceutical Association SAVINGS: An Economic Analysis of Generic Drug Usage in the U.S 2011 Generic Pharmaceutical Association Washington, DC
88. Press Release Newswire Mylan Launches Generic Version of Plavix Tablets Daily Finance 2012 http://www.reuters.com/article/2012/05/17/idus185632+17-may- 2012+prn20120517 Accessed November 2012
89. C.S. Stern, J. Lebowitz Latest drug developments in the field of cardiovascular disease Int J Angiol 19 2010 e100 e105
90. World Health Organization Cardiovascular Diseases (CVDs) 2012 WHO Geneva, Switzerland
91. Access Communications Cardiovascular Product and Disease Landscape Analysis Playbook: Prepared for the American College of Cardiology 2012 Access Communications San Francisco, CA
92. P. Mehta Cardiovascular Drug Research and Development. What's the Current State? IHS Healthcare and Pharma Blog: IHS, 2011 http://healthcare.blogs.ihs. com/2011/11/04/cardiovascular-drug-research-and-development-rd-whats-the- current-state Accessed November 2012
93. N. Bristol NIH proposes new drug development centre Lancet 377 2011 705 706
94. D. Wilson Drug Firms Face Billions in Losses in '11 as Patents End The New York Times March 6, 2011
95. Lucintel Global Cardiovascular Device Industry 2012-2017: Trends, Profits and Forecast Analysis Research and Markets, 2012 http://www.lucintel.com/ reports/medical/global-cardiovascular-device-industry-2012-2017-trends- foreacast-march-2012.aspx Accessed November 2012
96. Koncept Analytics Global Coronary Stent Market Report 2010 Edition http://www.konceptanalytics.com/reportdetail.aspx?reportid=255 Accessed November 2012
97. N. Echahidi, P. Pibarot, G. O'Hara, P. Mathieu Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery J Am Coll Cardiol 51 2008 793 801 (Pubitemid 351255619)
98. Abbott Laboratories Press Release: Abbott Initiates Clinical Trial to Evaluate the Absorb Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent 2011 Abbott Laboratories
99. Schwartz R. Bioabsorbable stents: design considerations. Slideshow presented at: Transcatheter Cardiovascular Therapeutics Conference; September 21-15, 2010; Washington, DC.
100. Medtronic Edwards Lifesciences Drive Percutaneous Aortic and Mitral Heart Valve Replacement and Repair Markets to over $1.3 Billion by 2017 2011 iData Research Vancouver, BC
101. S.K. Kodali, M.R. Williams, C.R. Smith Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
102. M.B. Leon, C.R. Smith, M. Mack Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
103. J.S. Sutherell, R. Hirsch, R.H. Beekman III Pediatric interventional cardiology in the United States is dependent on the off-label use of medical devices Congen Heart Dis 5 2010 2 7
104. S. Goodall, D.L. Gollaher Competitiveness and Regulation: The FDA and the Future of America's Biomedical Industry 2011 https://www.bcgperspectives.com/ content/articles/biopharma-medical-devices-technology-health-care- competitiveness-and-regulation-chi/ Accessed November 2012
105. J. Makower, A. Meer, L. Denend FDA Impact on U.S. Medical Technology Innovation: A Survey of Over 200 Medical Technology Companies 2010 http://www.nvca.org/index.php?option=com-docman&tak-doc-download&gid= 669&Itemid-93 Accessed November 2012
106. D.M. Zuckerman, P. Brown, S.E. Nissen Medical device recalls and the FDA approval process Arch Intern Med 171 2011 1006 1011
107. Food and Drug Administration Understanding Barriers to Medical Device Quality 2011 FDA Rockville, MD
108. R.G. Hauser, R. Abdelhadi, D. McGriff, L.K. Retel Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads Heart Rhythm 9 2012 1227 1235
109. R.G. Hauser Here we go again-failure of postmarketing device surveillance N Engl J Med 366 2012 873 875
110. Center for Devices and Radiological Health Strengthening Our National System for Medical Device Postmarket Surveillance 2012 U.S. Food and Drug Administration Silver Spring, MD
111. Medical Device Epidemiology Network Initiative (MDEpiNet) 2011 U.S. Food and Drug Administration Silver Spring, MD
112. A. Gaffney Report: FDA Developing UDI Barcode System for Medical Devices Regulatory Focus, 2012 http://www.raps.org/focus-online/news/news-article-view/ article/1371/report-fda-developing-udi-barcode-system-for-medical-devices.aspx Accessed November 2012
113. To Improve Postmarket Risk Identification and Analysis With Respect to Devices, and for Other Purposes 2012 U.S. Government Printing Office Washington, DC
114. J. Crowley The Use of UDI to Support Postmarket Surveillance and Compliance Activities 2011 U.S. Food and Drug Administration Silver Spring, MD
115. Edwards SAPIEN Transcatheter Heart Valve (THV)-P100041 Device Approvals and Clearances 2011 U.S. Food and Drug Administration Silver Spring, MD
116. STS and ACC Launch Joint Clinical Registry for Transcatheter Valve Therapy in the United States 2011 http://www.sts.org/news/sts-and-acc-launch- joint-clinical-registry-transcatheter-valve-therapy-united-states Accessed November 2012
117. Mayo Clinic Using Registries to Assess Clinical Practice and Improve Patient Care Clinical News, 2012 http://www.mayoclinic.org/medicalprofs/using- icd-registries.html Accessed November 2012
118. Centers for Medicare and Medicaid Services Decision Memo for Transcatheter Aortic Valve Replacement (TAVR) 2012 CMS Washington, DC
119. M. Brown CMS Delays Implementation of "Sunshine Act": Proposed Rule Sets New Deadline of March 2013 AAFP News Now 2012 http://www.aafp.org/ online/en/home/publications/news/news-now/government-medicine/ 20120105sunshinedelayed.html Accessed November 2012
120. K. Fiore Conflict-of-Interest Policies: A Detailed Look Medscape March 13, 2010
121. NIH HHS Tightens Financial Conflict of Interest Rules for Researchers NIH News 2011 National Institutes of Health Bethesda, MD
122. R. Thakkar AMSA's PharmFree Scorecard: U.S. Medical Schools Head in Right Direction to Avoid Conflict of Interest 2012 National Physician's Alliance Washington, DC
123. American Medical Student Association AMSA PharmFree Scorecard 2011-2012 2012 AMSA Reston, VA
124. G. Pham-Kanter, G.C. Alexander, K. Nair Effect of physician payment disclosure laws on prescribing Arch Intern Med 172 2012 819 821
125. S. Pelletier Are You Ready for the Sunshine Act? 2011 Medical Meetings New York, NY
126. Office of the Budget NIH National Institutes of Health FY 2013 Congressional Justification 2012 Dept Health and Human Services Washington, DC
127. ProposalExponent Federal R&D Funding: Quick Agency Profiles 2012 ProposalExponent Seattle, WA
128. Dept Health and Human Services National Institutes of Health: Executive Summary Office of the Budget NIH 2012 National Institutes of Health Bethesda, MD
129. Budget OoMa, Editor Fiscal Year 2012 Budget of the U.S. Government 2012 U.S. Government Printing Office Washington, DC
130. E.R. Dorsey, J. de Roulet, J.P. Thompson Funding of US biomedical research, 2003-2008 JAMA 303 2010 137 143
131. National Institutes of Health Report Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) 2012 National Institutes of Health Bethesda, MD
132. M.S. Lauer, S. Skarlatos Translational research for cardiovascular diseases at the National Heart, Lung, and Blood Institute: moving from bench to bedside and from bedside to community Circulation 121 2010 929 933
133. Cardiovascular Research Network Milestones 2012 Cardiovascular Research Network
134. Pharmaceutical Research and Manufacturers of America Pharmaceutical Industry Profile 2011 2011 Pharmaceutical Research and Manufacturers of America Washington, DC
135. A. Bhatt Quality of clinical trials: a moving target Perspect Clin Res 2 2011 124 128
136. S.W. Glickman, J.G. McHutchison, E.D. Peterson Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 2009 816 823
137. D.S. Jones, J.A. Greene The contributions of prevention and treatment to the decline in cardiovascular mortality: lessons from a forty-year debate Health Aff (Project Hope) 31 2012 2250 2258
138. G.P. Mays, S.A. Smith Evidence links increases in public health spending to declines in preventable deaths Health Aff (Project Hope) 30 2011 1585 1593
139. Morbidity and Mortality 2012 Chartbook on Cardiovascular, Lung and Blood Disease 2012 NIH, National Heart, Lung, and Blood Institute Bethesda, MD
140. E.S. Ford, U.A. Ajani, J.B. Croft Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398 (Pubitemid 46883773)
141. L. Goldman, E.F. Cook The decline in ischemic heart disease mortality rates An analysis of the comparative effects of medical interventions and changes in lifestyle Ann Intern Med 101 1984 825 836 (Pubitemid 15187377)
142. M.G. Hunink, L. Goldman, A.N. Tosteson The recent decline in mortality from coronary heart disease, 1980-1990 The effect of secular trends in risk factors and treatment JAMA 277 1997 535 542 (Pubitemid 27083982)
143. Health Policy Brief: The Prevention and Public Health Fund Health Affairs 2012 http://healthaffairs.org/blog/2012/03/01/health-policy-brief-the- prevention-and-public-health-fund Accessed November 2012
144. B.D. Sommers, L. Wilson Fifty-Four Million Additional Americans Are Receiving Preventive Services Coverage Without Cost-Sharing Under the Affordable Care Act Issue Brief: ASPE Office of Health Policy 2012 Dept Health and Human Services Washington, DC
145. Recommended Preventive Services Washington, DC: Dept Health and Human Services http://www.healthcare.gov
146. Internal Revenue Service EBSA, Centers for Medicare and Medicaid Services Group Health Plans and Health Insurance Issuers Relating to Coverage of Preventive Services Under the Patient Protection and Affordable Care Act Fed Register 77 2012 8725 8730
147. K. Baicker, D. Cutler, Z. Song Workplace wellness programs can generate savings Health Aff (Project Hope) 29 2010 304 311
148. I. Graham, D. Atar, K. Borch-Johnsen European guidelines on cardiovascular disease prevention in clinical practice Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice Eur J Cardiovasc Prevent Rehab 14 Suppl 2 2007 1 113
149. G. De Backer, E. Ambrosioni, K. Borch-Johnsen European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice Eur J Cardiovasc Prevent Rehab 10 Suppl 2003 1 10
150. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
151. J. Genest, R. McPherson, J. Frohlich 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations Can J Cardiol 25 2009 567 579
152. M.T. Cooney, A. Dudina, R. D'Agostino, I.M. Graham Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation 122 2010 300 310
153. E. Pimenta, D.A. Calhoun Resistant hypertension: incidence, prevalence, and prognosis Circulation 125 2012 1594 1596
154. S.L. Daugherty, J.D. Powers, D.J. Magid Incidence and prognosis of resistant hypertension in hypertensive patients Circulation 125 2012 1635 1642
155. D.A. Calhoun, D. Jones, S. Textor Resistant hypertension: diagnosis, evaluation, and treatment A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 51 2008 1403 1419
156. S.S. Yoon, V. Burt, T. Louis, M.D. Carroll Hypertension among adults in the United States, 2009-2010 NCHS Data Brief, No. 107 2012 National Center for Health Statistics Hyattsville, MD
157. B.M. Egan, Y. Zhao, R.N. Axon, W.A. Brzezinski, K.C. Ferdinand Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008 Circulation 124 2011 1046 1058
158. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
159. R.A. Hayward, H.M. Krumholz Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health Circ Cardiovasc Qual Outcome 5 2012 2 5
160. M.D. Carroll, B.K. Kit, D.A. Lacher Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2009-2010 NCHS Data Brief, No. 92 2012 National Center for Health Statistics Hyattsville, MD 1 8
161. National Center for Health Statistics (US) Health, United States, 2010: With Special Feature on Death and Dying National Center for Health Statistics (US): Prevention 2011 NCHS Hyattsville MD http://www.ncbi.nlm.nih.gov/books/ nbk54386 Accessed June 2012
162. M.J. Blaha, K. Nasir, R.S. Blumenthal Statin therapy for healthy men identified as "increased risk." JAMA 307 2012 1489 1490
163. R.F. Redberg, M.H. Katz Healthy men should not take statins JAMA 307 2012 1491 1492
164. L.S. Lim, T.Y. Wong Fibrate use in the United States and Canada JAMA 306 2011 157 158 author reply 158-9
165. H.N. Ginsberg The ACCORD (Action to Control Cardiovascular Risk in Diabetes) lipid trial: what we learn from subgroup analyses Diabetes Care 34 Suppl 2 2011 107 108
166. P.J. Barter, K.A. Rye Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk J Lipid Res 53 2012 1755 1766
167. REVEAL Randomized Evaluation of the Effects of Anacetrapib Through Lipid-Modification 2012 U.S. National Institutes of Health http://www. clinicaltrials.gov Accessed November 2012
168. R. Miller Roche stops dalcetrapib trial for lack of benefit The Heartwire 2012 Theheart.org Basel, Switzerland
169. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 2004 NHLBI Bethesda, MD
170. K.M. Flegal, B.I. Graubard, D.F. Williamson, M.H. Gail Excess deaths associated with underweight, overweight, and obesity JAMA 293 2005 1861 1867 (Pubitemid 40548182)
171. C.L. Ogden, M.D. Carroll, B.K. Kit, K.M. Flegal Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010 JAMA 307 2012 483 490
172. C.L. Ogden, M.D. Carroll, B.K. Kit, K.M. Flegal Prevalence of obesity in the United States, 2009-2010 NCHS Data Brief, No. 82 2012 National Center for Health Statistics Hyattsville, MD 1 8
173. V.L. Roger, A.S. Go, D.M. Lloyd-Jones Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
174. American Diabetes Association Diabetes Statistics 2011 ADA Alexandria, VA
175. J.P. Boyle, T.J. Thompson, E.W. Gregg, L.E. Barker, D.F. Williamson Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence Pop Health Metrics 8 2010 29
176. National Committee for Quality Assurance State of Health Care Quality: Continuous Improvement and the Expansion of Quality Measurement 2011 NCQA Washington, DC
177. E.W. Gregg, Y.J. Cheng, S. Saydah Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey Diabetes Care 35 2012 1252 1257
178. D.M. Nathan, J.B. Buse, M.B. Davidson Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 2009 193 203
179. H.W. Rodbard, P.S. Jellinger, J.A. Davidson Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: an algorithm for glycemic control Endocr Pract 15 2009 540 559
180. J.M. McWilliams, E. Meara, A.M. Zaslavsky, J.Z. Ayanian Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of Medicare coverage Ann Intern Med 150 2009 505 515
181. J.B. Saaddine, B. Cadwell, E.W. Gregg Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002 Ann Intern Med 144 2006 465 474 (Pubitemid 46780669)
182. American Heart Association Statistical Fact Sheet 2012 Update http://www.heart.org/idc/groups/heart-public/@wcm/@sop/smd/documents/ downloadable/ucm-319831.pdf Accessed November 2012
183. P.S. Chan, W.J. Oetgen, D. Buchanan Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program J Am Coll Cardiol 56 2010 8 14
184. S.V. Arnold, J.A. Spertus, F. Tang Statin use in outpatients with obstructive coronary artery disease Circulation 124 2011 2405 2410
185. V. Aboyans, D. Thomas, P. Lacroix The cardiologist and smoking cessation Curr Opin Cardiol 25 2010 469 477
186. J.P. Drozda Jr., D.P. Holmes Jr Performance measures in million hearts: 2 partners' perspective Circ Cardiovasc Qual Outcome 5 2012 587 588
187. Q. Yang, M.E. Cogswell, W.D. Flanders Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults JAMA 307 2012 1273 1283
188. Prevalence of no leisure-time physical activity-35 states and the District of Columbia, 1988-2002 MMWR Morbid Mortal Weekly Rep 53 2004 82 86
189. Department of Health and Human Services Physical Activity Guidelines for Adults 2009 http://www.health.gov/paguidelines Accessed November 2012